Image 4
Image 3
Image 1
Image 2
Image 5
focusing on the patient

Welcome to
OLM Innovations

OLM Innovations is committed to supporting the development of new and innovative diagnostic products with clear clinical benefits.

We will guide the process from inception to commercialisation, using our international network of specialists and decision makers in the medical sector to help give products the best possible chance of success.

Find out more about OLM innovations here.

Company News

rss_button
Journal of Infection publishes Martin Hoenigl paper
26/04/2013

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients.

Journal of Clinical Microbiology publishes Lewis White paper
26/04/2013

Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a Novel Lateral-Flow Device for Diagnosis of Invasive Aspergillosis

Visit the news archive

Industry News

rss_button
The PDR-type ABC transporters AtrA and AtrG are involved in azole drug resistance in Aspergillus oryzae.
18/07/2018

The PDR-type ABC transporters AtrA and AtrG are involved in azole drug resistance in Asperg

TGF-β/SMAD4 mediated UCP2 downregulation contributes to Aspergillus protease-induced inflammation in primary bronchial epithelial cells.
18/07/2018

Related Articles TGF-β/SMAD4 mediated UCP2 downregulation contributes to Aspergillus proteas

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis.
18/07/2018

Related Articles Histological Quantification to Determine Lung Fungal Burden in Experiment

Visit the news archive